| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 08/12/2004 | WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 08/12/2004 | WO2004067506A2 Substituted heterocyclic compounds |
| 08/12/2004 | WO2004052280A3 Anti-angiogenic compounds and their use in cancer treatment |
| 08/12/2004 | WO2004048351A3 Biphenyl compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 08/12/2004 | US20040157881 Function regulator for retinoid relative receptor |
| 08/12/2004 | US20040157740 For controlling harmful organisms |
| 08/12/2004 | CA2513641A1 Substituted heterocyclic compounds |
| 08/11/2004 | EP1444739A2 Light emitting device and compounds for use therein |
| 08/11/2004 | CN1519235A Compound of permitting electtronic migration and emitting photoluminescence radiation structure and its application |
| 08/10/2004 | US6774138 To function as agonists or antagonists of receptors for neurotransmitters, neurohormones and neuromodulators, as insecticides and fingicides |
| 08/05/2004 | WO2004065360A2 Piperazine derivatives and their use as synthesis intermediates |
| 08/05/2004 | WO2004064972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 08/05/2004 | US20040152743 Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals |
| 08/05/2004 | US20040152699 Compounds |
| 08/05/2004 | US20040151945 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 08/05/2004 | CA2514145A1 Piperazine derivatives and their use as synthesis intermediates |
| 08/04/2004 | EP1443041A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 08/04/2004 | EP1441721A2 Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 08/04/2004 | EP1165721B1 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring |
| 08/04/2004 | EP1077957B1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 07/29/2004 | WO2004046091A3 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/29/2004 | US20040147701 Molecular chemical compounds with structures allowing electron displacement and capable of emitting photoluminescent radiation, and photoluminescence quenching device employing the same |
| 07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | CN1516695A Arylsulfonamides as antiviral agents |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/27/2004 | CA2243591C Halogen pyrimidines and its use thereof as parasite abatement means |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents |
| 07/22/2004 | US20040142985 Heterocyclic compounds useful to treat HCV |
| 07/22/2004 | US20040142981 Sterilization, antiseptics for bacteria infections |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142948 Cardiovascular disorders; hypotensive agents ; respiratory system disorders; antiinflammatory agents; restenosis ; antiarthritic agents; atherosclerosis; anticholesterol agents; Alzheimer's disease; antidiabetic agents |
| 07/22/2004 | US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process. |
| 07/22/2004 | US20040139563 7-Nitro-2,1,3-benzoxadiazole and 7-nitro-2,1,3-benzthiadiazole derivatives, as well dyeing agents for keratin fibers containing these compounds |
| 07/22/2004 | US20040139562 safe from toxicological and dermatological points of view and make it possible to achieve dyeings of the desired intensity; have a good light fastness, acid fastness, crocking resistance and good stability when washed. |
| 07/21/2004 | CN1514823A 草酸衍生物 Oxalic acid derivatives |
| 07/15/2004 | WO2004035736A3 Halogenated selective androgen receptor modulators and methods of use thereof |
| 07/15/2004 | WO2004014881B1 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138468 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/15/2004 | US20040138467 Controlling electroconductors and structures for computers or semiconductors |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138274 Novel pharmaceuticals |
| 07/15/2004 | US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040138197 Therapeutic use of aryl amino acid derivatives |
| 07/14/2004 | EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1435950A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/08/2004 | WO2004056789A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivates |
| 07/08/2004 | WO2004056787A1 Cyclopentyl glutaramides and their use as neutral endopeptidase inhibitors |
| 07/08/2004 | US20040132787 e.g., 2-methyl-2-{4-[3-(4-tert-Butyl-phenyl)-[1,2,4]oxadiazol-5-ylmethoxy]-2-methyl-phenoxy}propionic acid or its ethyl ester; dyslipidemia, syndrome X, heart failure, hypercholesteremia, cardiovascular disease, diabetes, anorexia, etc. |
| 07/08/2004 | US20040132726 New compounds |
| 07/08/2004 | CA2511360A1 Novel pharmaceuticals |
| 07/08/2004 | CA2509405A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivatives |
| 07/07/2004 | EP1071670B1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 07/06/2004 | US6759538 Substituted diphenyl heterocycles useful for treating HCV infection |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/01/2004 | WO2004014357A3 Therapeutic use of aryl amino acid derivatives |
| 07/01/2004 | US20040127718 Substituted imidazoles |
| 07/01/2004 | US20040127560 compounds with high binding affinity for the glucagon receptor, such as: 3-{4-[1-(4-cyclohexylphenyl)-3-(3-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid; antidiabetic agents; antiobesity agent; antihypertensive agent |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 06/30/2004 | EP1080081B1 Benzofuroxan derivatives and their use in treating angina pectoris |
| 06/29/2004 | US6756406 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 06/29/2004 | US6756216 Batch processing using nucleophilic compound |
| 06/24/2004 | WO2004052840A1 Compounds which modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/24/2004 | WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment |
| 06/24/2004 | US20040122066 Oxadiazole derivatives having anticancer effects |
| 06/24/2004 | US20040122057 Novel mandelic acid derivatives |
| 06/24/2004 | CA2506732A1 Compounds which modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | US20040116483 Glucagon antagonists/inverse agonists |
| 06/17/2004 | US20040116404 Sulphones which modulate the action of gamma secretase |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/16/2004 | EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications |
| 06/16/2004 | EP1428534A1 Benzofurazan derivatives for enhancing glutamatergic synaptic responses |
| 06/16/2004 | EP1428531A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/16/2004 | EP1089963B1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6749645 Use of 4-nitro-2,1,3,-benzoxadiazole derivatives as dyes in coloring agents for keratin fibres |
| 06/10/2004 | WO2004048351A2 Biphenyl compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 06/10/2004 | WO2004048335A2 Mandelic acid derivatives |
| 06/10/2004 | WO2004048309A1 Vitamin d receptor modulators |
| 06/10/2004 | US20040110951 thiazolidinedione, oxadiazolidinedione, and triazolone compounds treating obesity, overweight condition, hyperlipidemia, glaucoma, cardiac arrhythmias, skin disorders, thyroid disease, hypothyroidism, thyroid cancer, diabetes, etc. |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | CA2505542A1 Mandelic acid derivatives |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/08/2004 | US6747041 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 06/08/2004 | US6746989 Substituted benzoylpyrazoles as herbicides |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/03/2004 | WO2004046090A2 Aryl ureido derivatives and their medical use |